207 related articles for article (PubMed ID: 35349757)
1. COVID-19 associated EBV reactivation and effects of ganciclovir treatment.
Meng M; Zhang S; Dong X; Sun W; Deng Y; Li W; Li R; Annane D; Wu Z; Chen D
Immun Inflamm Dis; 2022 Apr; 10(4):e597. PubMed ID: 35349757
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of EBV and CMV in Severe COVID-19-Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients.
Naendrup JH; Garcia Borrega J; Eichenauer DA; Shimabukuro-Vornhagen A; Kochanek M; Böll B
J Intensive Care Med; 2022 Sep; 37(9):1152-1158. PubMed ID: 34791940
[TBL] [Abstract][Full Text] [Related]
3. Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients.
Chen T; Song J; Liu H; Zheng H; Chen C
Sci Rep; 2021 May; 11(1):10902. PubMed ID: 34035353
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of primary Epstein-Barr virus infection disease spectrum and its reactivation in children, in Suzhou, China.
Shi T; Huang L; Chen Z; Tian J
J Med Virol; 2021 Aug; 93(8):5048-5057. PubMed ID: 33719067
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and outcomes of critically ill patients with acute COVID-19 with Epstein-Barr virus reactivation.
Xie Y; Cao S; Dong H; Lv H; Teng X; Zhang J; Wang T; Zhang X; Qin Y; Chai Y; Yang L; Liu J; Wang R
BMC Infect Dis; 2021 Sep; 21(1):955. PubMed ID: 34525962
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus reactivation is not causative for post-COVID-19-syndrome in individuals with asymptomatic or mild SARS-CoV-2 disease course.
Hoeggerl AD; Nunhofer V; Lauth W; Badstuber N; Held N; Zimmermann G; Grabmer C; Weidner L; Jungbauer C; Lindlbauer N; Neureiter H; Ortner T; Flamm M; Osterbrink J; Rohde E; Laner-Plamberger S
BMC Infect Dis; 2023 Nov; 23(1):800. PubMed ID: 37968601
[TBL] [Abstract][Full Text] [Related]
7. Features of Epstein-Barr Virus and Cytomegalovirus Reactivation in Acute Leukemia Patients After Haplo-HCT With Myeloablative ATG-Containing Conditioning Regimen.
Ru Y; Zhu J; Song T; Ding Y; Zhu Z; Fan Y; Xu Y; Sun A; Qiu H; Jin Z; Tang X; Han Y; Fu C; Chen S; Ma X; Chen F; Chen J; Wu D
Front Cell Infect Microbiol; 2022; 12():865170. PubMed ID: 35651756
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients.
Bernal KDE; Whitehurst CB
Virus Res; 2023 Sep; 334():199157. PubMed ID: 37364815
[TBL] [Abstract][Full Text] [Related]
9. Valganciclovir suppressed Epstein Barr virus reactivation during immunosuppression with alemtuzumab.
Gill H; Hwang YY; Chan TS; Pang AW; Leung AY; Tse E; Kwong YL
J Clin Virol; 2014 Apr; 59(4):255-8. PubMed ID: 24507802
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
Nystad TW; Myrmel H
J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
[TBL] [Abstract][Full Text] [Related]
11. Differential Reactivation of Cytomegalovirus and Epstein-Barr Virus in Patients with B Cell Lymphoma.
Hatayama Y; Watanabe K; Ichikawa H; Kawamura K; Fukuda T; Motokura T
Viral Immunol; 2023 Oct; 36(8):520-525. PubMed ID: 37440168
[TBL] [Abstract][Full Text] [Related]
12. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A
PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658
[TBL] [Abstract][Full Text] [Related]
13. Epstein Barr Virus Reactivation during COVID-19 Hospitalization Significantly Increased Mortality/Death in SARS-CoV-2(+)/EBV(+) than SARS-CoV-2(+)/EBV(-) Patients: A Comparative Meta-Analysis.
Manoharan S; Ying LY
Int J Clin Pract; 2023; 2023():1068000. PubMed ID: 36793928
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity.
Aygun D; Kuskucu MA; Sahin S; Adrovic A; Barut K; Yıldız M; Sharifova S; Midilli K; Cokugras H; Camcıoglu Y; Kasapcopur O
Lupus; 2020 Sep; 29(10):1263-1269. PubMed ID: 32646294
[TBL] [Abstract][Full Text] [Related]
15. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
Seishima M; Yamanaka S; Fujisawa T; Tohyama M; Hashimoto K
Br J Dermatol; 2006 Aug; 155(2):344-9. PubMed ID: 16882173
[TBL] [Abstract][Full Text] [Related]
16. Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients.
Hornef MW; Bein G; Fricke L; Steinhoff J; Wagner HJ; Hinderer W; Sonneborn HH; Kirchner H
Transplantation; 1995 Sep; 60(5):474-80. PubMed ID: 7676497
[TBL] [Abstract][Full Text] [Related]
17. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
[TBL] [Abstract][Full Text] [Related]
18. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus reactivation during pregnancy and postpartum: effects of race and racial discrimination.
Christian LM; Iams JD; Porter K; Glaser R
Brain Behav Immun; 2012 Nov; 26(8):1280-7. PubMed ID: 22940537
[TBL] [Abstract][Full Text] [Related]
20. Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus.
Wood RA; Guthridge L; Thurmond E; Guthridge CJ; Kheir JM; Bourn RL; Wagner CA; Chen H; DeJager W; Macwana SR; Kamp S; Lu R; Arriens C; Chakravarty EF; Thanou A; Merrill JT; Guthridge JM; James JA
J Transl Autoimmun; 2021; 4():100117. PubMed ID: 35005588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
